Postmarket safety communications on drugs approved in Japan: A 25‐year analysis

• Asıl Yazarlar: Yusuke Tanaka (Yazar), Mototsugu Tanaka (Yazar), Haruna Miyazawa (Yazar), Ryohei Terashima (Yazar), Makoto Miyazawa (Yazar), Mutsuhiro Ikuma (Yazar), Yoshihiko Tomita (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2024-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Drug safety communications (DSCs) are essential tools for communicating important postmarket serious drug safety information to healthcare professionals and patients. Previous studies characterized DSCs issued by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency...